Attached files

file filename
EX-10.54 - EX 10.54 - ARRAY BIOPHARMA INCex1054saccomanoempagreement.htm
EX-31.1 - EX 31.1 - ARRAY BIOPHARMA INCa063014ex311.htm
EX-10.52 - EX 10.52 - ARRAY BIOPHARMA INCex1052loxoamend1.htm
EX-31.2 - EX 31.2 - ARRAY BIOPHARMA INCa063014ex312.htm
EX-23.1 - EX 23.1 - ARRAY BIOPHARMA INCa063014ex231.htm
EXCEL - IDEA: XBRL DOCUMENT - ARRAY BIOPHARMA INCFinancial_Report.xls
10-K - FORM 10-K - ARRAY BIOPHARMA INCa06301410-k.htm
EX-10.53 - EX 10.53 - ARRAY BIOPHARMA INCex1053loxoamend2.htm


Exhibit 32.1


CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with this annual report of Array BioPharma Inc. (the “Registrant”) on Form 10-K for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(a)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.


Date:
August 14, 2014
/s/ RON SQUARER
 
 
Ron Squarer
 
 
Chief Executive Officer
 
 
 
 
 
 
 
 
/s/ R. MICHAEL CARRUTHERS
 
 
R. Michael Carruthers
 
 
Chief Financial Officer
 
 
(Principal Financial and Accounting Officer)